Characterization of synthetic routes to 'Bromo-DragonFLY' and benzodifuranyl isopropylamine homologues utilizing ketone intermediates. Part 1: Synthesis of ketone precursors

Drug Testing and Analysis

Volumn 6, Issue 7-8, 2014, Pages 658-667

  O'Connor, Richard E ^a   Keating, John J ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Amphetamine type stimulants (ATS); Bromo dragonFLY; Clandestine synthesis; Ketone precursors; Novel psychoactive substances (NPS)

Indexed keywords

ACETONE; DRUG PRODUCTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AMPHETAMINE-TYPE STIMULANT; BROMO-DRAGONFLY; CLANDESTINE SYNTHESIS; ISOPROPYLAMINE; KETONE PRECURSOR; METHYL KETONES; NOVEL PRECURSORS; NOVEL PSYCHOACTIVE SUBSTANCE; RECREATIONAL DRUGS; SYNTHETIC ROUTES;

MASS SPECTROMETRY;

AMPHETAMINE DERIVATIVE; BENZODIFURANYL ISOPROPYLAMINE DERIVATIVE; KETONE DERIVATIVE; UNCLASSIFIED DRUG; 1-(8-BROMOBENZO(1,2-B;4,5-B')DIFURAN-4-YL)-2-AMINOPROPANE; 2-PROPYLAMINE; BROMOBENZOIC ACID DERIVATIVE; KETONE; PROPYLAMINE; STREET DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; SYNTHESIS; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BROMOBENZOATES; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; KETONES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PROPYLAMINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STREET DRUGS;

EID: 84904552586     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1504     Document Type: Article

References (46)

1. Psychonaut WebMapping Research Group. Bromo-Dragonfly Report. Institute of Psychiatry, King's College London, London UK, 2009.
2. EMCDDA. Technical profile of bromodragonfly. Available at: http://ewsd.wiv-isp.be/Publications%20on%20new%20psychoactive%20substances/Bromo-dragonfly/BDF_Tech_Prof_EMCDDA_Mar_2010.pdf [8 April 2013].
3. O. Corazza, F. Schifano, M. Farre, P. Deluca, Z. Davey, C. Drummond, et al. Designer drugs on the internet: A phenomenon out-of-control? The emergence of hallucinogenic drug bromo-dragonfly. Curr. Clin. Pharmacol. 2011, 6, 125.
4. M. Coppola, R. Mondola . Bromo-dragonFly: Chemistry, pharmacology and toxicology of a benzodifuran derivative producing LSD-like effects. J. Addict. Res. Ther. 2012, 3, 133.
5. 2A receptor. J. Med. Chem. 1998, 41, 5148.
6. 2A/2C receptor agonists. J. Med. Chem. 2001, 44, 1003.
7. Bromo-dragonfly - life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case. Available at: http://www.lakartidningen.se/engine.php?articleId=9254 [21 May 2013].
8. D.M. Wood, J.J. Looker, L. Shaikh, J. Button, M. Puchnarewicz, S. Davies, et al. Delayed onset of seizures and toxicity associated with recreational use of bromo-dragonFLY. J. Med. Toxicol. 2009, 5, 226.
9. M.F. Andreasen, R. Telving, R.I. Dupont Birkler, B. Schumacher, M. Johannsen . A fatal poisoning involving Bromo-Dragonfly. Forensic Sci. Int. 2009, 183, 91.
10. S.L. Hill, S.H. Thomas . Clinical toxicology of newer recreational drugs. Clin. Toxicol. 2011, 49, 705.
11. 2CB-FLY Warning. Pill Reports. Available at: http://www.pillreports.com/index.php?page=display_pill&id=19118 [8 April 2013].
12. Information on reported deaths related to 2C-B-Fly. Erowid. Available at: http://www.erowid.org/chemicals/2cb_fly/2cb_fly_death1.shtml [8 April 2013].
13. Bromodragonfly mislabeled as 2-CE caused two deaths in Oklahoma. The Posion Review. Available at: http://www.thepoisonreview.com/2011/11/10/bromodragonfly-mislabeled-as-2c-e-caused-two-deaths-in-oklahoma/ [8 April 2013].
14. U.S. Department of Justice Drug Enforcement Administration. 'Bromo dragonfly' in Queensland, Australia. Microgr. Bull. 2008, 41(2), 16.
15. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)-Europol. Annual report on the implementation of Council decision 2005/387/JHA. In accordance with Article 10 of Council decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances. Lisbon, Portugal. 2006, 7.
16. Misuse of Drugs Act 1977. Controlled Drugs, Declaration. Order S.I. 551/2011, Ireland, 2011.
17. A.P. Monte, D. Marona-Lewicka, M.A. Parker, D.B. Wainscott, D.L. Nelson, D.E. Nichols . Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2, 5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy Groups. J. Med. Chem. 1996, 39, 2953.
18. D.E. Nichols, S.E. Snyder, R. Oberlender, M.P. Johnson, X. Huang . 2, 3-Dihydrobenzofuran analogues of hallucinogenic phenethylamines. J. Med. Chem. 1991, 34, 276.
19. A.P. Monte, S.R. Waldman, D. Marona-Lewicka, D.B. Wainscott, D.L. Nelson, E. Sanders-Bush, et al. Dihydrobenzofuran analogues of hallucinogens. 4. mescaline derivatives. J. Med. Chem. 1997, 40, 2997.
20. D.M. Schultz, J.A. Prescher, S. Kidd, D. Marona-Lewicka, D.E. Nichols, A. Monte . 'Hybrid' benzofuran-benzopyran congeners as rigid analogs of hallucinogenic phenethylamines. Bioorg. Med. Chem. 2008, 16, 6242.
21. 2A receptor ligands. Bioorg. Med. Chem. 2008, 16, 4661.
22. S. Di Giovanni, A. Varriale, V.M. Marzullo, G. Ruggiero, M. Staiano, A. Secchi, et al. Determination of benzyl methyl ketone - a commonly used precursor in amphetamine manufacture. Anal. Method 2012, 4, 3558.
23. M. Collins . Some new psychoactive substances: Precursor chemicals and synthesis-driven end-products. Drug Test. Anal. 2011, 3, 404.
24. A. Allen, T.S. Cantrell . Synthetic reductions in clandestine amphetamine and methamphetamine laboratories - a review. Forensic Sci. Int. 1989, 42, 183.
25. A.B.E. Theeuwen, A.M.A. Verweij . Impurities in illicit amphetamine. 7. Identification of benzyl methyl ketone phenylisopropylimine and benzyl methyl ketone benzylimine in amphetamine. Forensic Sci. Int. 1980, 15, 237.
26. J.J. Keating . Studies in the synthesis and impurity profiling of methylenedioxy and alkythioamphetamines. PhD thesis. Trinity College, Dublin, 2001.
27. D.M. Griffin . Studies in the synthesis and impurity profiling of 2, 5-dimethoxy amphetamines. PhD thesis. University College Cork, Cork, 2009.
28. S.M. Cloonan, J.J. Keating, D. Corrigan, J.E. O'Brien, P.V. Kavanagh, D.C. Williams, et al. Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted α-alkylthioamphetamines. Bioorg. Med. Chem. 2010, 18, 4009.
29. A. Siwinska-Ziolkowska, D. Blachut, E. Widecka-Deptuch . Identification of impurities in biological material remaining after amphetamine synthesis. Probl. Forensic Sci. 2004, 60, 130.
30. D.S. Pedersen, C. Rosenbohm . Dry column vacuum chromatography. Synthesis 2001, 16, 2431.
31. L. Rene, J.P. Buisson, R. Royer, D. Averbeck . Difurobenzene and furochromene analogs of psoralen and pseudopsoralen. Eur. J. Med. Chem. 1977, 12, 31.
32. Y.M. McNamara, S.M. Cloonan, A.J.S. Knox, J.J. Keating, S.G. Butler, G.H. Peters, et al. Synthesis and serotonin transporter activity of 1, 3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents. Bioorg. Med. Chem. 2011, 19, 1328.
33. A.T. Shulgin, A. Shulgin . PiHKAL: A Chemical Love Story. Transform Press, California, 1991.
34. D.D. Das, A. Nayak, B. Nanda, N.B. Das . Microwave-assisted transformation of, α, β- and, β, γ-unsaturated nitroalkenes into carbonyl compounds. J. Chem. Research 2006, 8, 481.
35. P.K. Pradhan, S. Dey, P. Jaisankar, V.S. Giri . Fe-HCl: An efficient reagent for deprotection of oximes as well as selective oxidative hydrolysis of nitroalkenes and nitro-alkanes to ketones. Synthetic Commun. 2005, 35, 913.
36. H.B. Hass, A.G. Susie, R.L. Heidler . Nitro alkene derivatives. J. Org. Chem. 1950, 15, 8.
37. D. Monti, P. Gramatica, G. Speranza, P. Manito . Reaction of nitroolefins with Raney nickel and sodium hypophosphite. A mild method for converting nitroolefins into ketones (or aldehydes). Tetrahedron Lett. 1983, 24, 417.
38. 2A receptor agonists with ocular hypotensive activity. Bioorg. Med. Chem. Lett. 2007, 17, 2998.
39. I. Pravst, M. Zupa, S. Stavber . Directed regioselectivity of bromination of ketones with NBS: Solvent-free conditions versus water. Tetrahedron Lett. 2006, 47, 4707.
40. M.C. Carreno, J.L. Garcia Ruano, G. Sanz, M.A. Toledo, A. Urbano, N-Bromosuccinimide in acetonitrile: A mild and regiospecific nuclear brominating reagent for methoxybenzenes and naphthalenes. J. Org. Chem. 1995, 60, 5328.
41. E. Zysman-Colman, K. Arias, J.S. Siegel . Synthesis of arylbromides from arenes and N-bromosuccinimide (NBS) in acetonitrile - A convenient method for aromatic bromination. Can. J. Chem. 2009, 87, 440.
42. M.M. Pedemonte, I.N. Munoz, M.S. Lopez, D.M. Julian, M. Rosol, A.L. Soldevila, J.A. Bofarull . Crystax Pharmaceuticals. New compounds as HSP90 inhibitors. WO Patent No. 2009/007399, 2009.
43. M. Saitoh, J. Kunitomo, E. Kimura, Y. Hayase, H. Kobayashi, N. Uchiyama, et al. Design, synthesis and structure-activity relationships of 1, 3, 4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β. Bioorg. Med. Chem. 2009, 17, 2017.
44. T. Lu, R. Alexander, R.W. Connors, M.D. Cummings, R.A. Galemmo, H.R. Hufnagel, et al. Janssen Pharmaceutica. Triazolopyridazines as tyrosine kinase modulators. WO Patent No. 2007075567, 2007.
45. J.C. Gonzalez-Gomez, L. Santana, E. Uriarte . A furan ring expansion approach to the synthesis of novel pyridazino-psoralen derivatives. Tetrahedron 2005, 61, 4805.
46. T. Awad, J. DeRuiter, C.R. Clark . Gas chromatography-mass spectrometry analysis of regioisomeric ring substituted methoxy methyl phenylacetones. J. Chromatogr. Sci. 2007, 45, 458.